Portfolio includes five investigational gene therapy programs for glycogen storage disorders that have no existing FDA-approved tr...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — December 20, 2021 — Kriya Therapeutics, Inc., a fully integrated comp...
– Dr. Heah brings extensive leadership and clinical experience to the company and will lead the new division’s overall strategy, clinical, regulatory and business development activities
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — July 28, 2021 — Kriya Therapeutics, Inc., a fully integrated platfor...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., — July 14, 2021 — Kriya Therapeutics, Inc., a fully integrated platfor...
Kriya Therapeutics Strengthens Leadership Team with the Appointment of Dr. Ilise Lombardo as Chief Medical Officer So...
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Sept. 3, 2020 /PRNewswire/ — Kriya Therapeutics, a next generation gene t...
51,350 square foot operational manufacturing facility based in Research Triangle Park, North Carolina is designed to have its own...
Kriya is focused on rationally designed gene therapies for severe chronic conditions affecting millions of patients Financi...